Liberty One Investment Management LLC Boosts Stock Holdings in Cardinal Health, Inc. $CAH

Liberty One Investment Management LLC lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 101.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 432,951 shares of the company’s stock after acquiring an additional 217,826 shares during the quarter. Cardinal Health comprises approximately 3.8% of Liberty One Investment Management LLC’s holdings, making the stock its 2nd largest position. Liberty One Investment Management LLC’s holdings in Cardinal Health were worth $67,950,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in CAH. Geode Capital Management LLC boosted its position in Cardinal Health by 3.3% during the second quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after purchasing an additional 205,539 shares during the period. Norges Bank acquired a new stake in shares of Cardinal Health in the second quarter worth $584,420,000. Invesco Ltd. lifted its stake in shares of Cardinal Health by 7.3% in the second quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock worth $510,347,000 after buying an additional 207,750 shares during the last quarter. Legal & General Group Plc grew its stake in Cardinal Health by 2.0% in the 2nd quarter. Legal & General Group Plc now owns 2,349,767 shares of the company’s stock valued at $394,761,000 after buying an additional 45,812 shares during the last quarter. Finally, Marshall Wace LLP raised its holdings in Cardinal Health by 19.1% in the 2nd quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock worth $324,402,000 after acquiring an additional 309,335 shares during the period. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Up 0.7%

Shares of CAH opened at $202.42 on Tuesday. The stock’s 50-day moving average price is $204.29 and its 200 day moving average price is $173.48. The firm has a market capitalization of $48.10 billion, a price-to-earnings ratio of 30.53, a P/E/G ratio of 1.46 and a beta of 0.65. Cardinal Health, Inc. has a 12-month low of $119.25 and a 12-month high of $214.93.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter last year, the company earned $1.88 EPS. The company’s quarterly revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Equities research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s payout ratio is currently 30.77%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on CAH shares. Leerink Partners upped their price target on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a report on Monday, November 17th. TD Cowen increased their target price on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 3rd. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $190.00 to $244.00 in a report on Friday. Wells Fargo & Company lifted their price target on Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Finally, UBS Group increased their price objective on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Fourteen equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $213.40.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.